Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,617 INR | -0.58% | +2.38% | +1.53% |
May. 14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
May. 13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.53% | 2.63B | |
-24.63% | 7.83B | |
+68.36% | 4.32B | |
-7.01% | 2.53B | |
-42.85% | 2.29B | |
-11.99% | 1.82B | |
-20.68% | 1.51B | |
+17.83% | 1.22B | |
-42.71% | 1.17B | |
+17.33% | 957M |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6%